Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

DARK SECRETS: 2 | Rare Historical Photos

Cash Flow Focus: Thermo Fisher, Energy Transfer, and NetEase

Companies with strong cash flow and a history of impressing Wall Street analysts may make excellent prospects for 2025; TMO, ET, and NTES are three to watch.

MarketBeat

How Is Thermo Fisher Scientific’s Stock Performance Compared to Other Medical Devices Stocks?

While Thermo Fisher Scientific has underperformed the broader medical device industry recently, analysts remain optimistic about the company's future outlook.

Barchart

Thermo Fisher Scientific Stock: Is TMO Underperforming the Healthcare Sector?

Thermo Fisher Scientific recently underperformed the healthcare sector, but Wall Street analysts are bullish about the stock’s prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Thermo Fisher Earnings Preview: What to Expect

Thermo Fisher is expected to release its fiscal second-quarter earnings this month, and analysts project a slight decrease in profit.

Barchart

Thermo Fisher stops sale of DNA kits in Tibet after activists raised fears of rights abuses

Campaigners say testing is among methods used to surveil people in the tightly controlled region

The Guardian - UK

US biotech company halts sales of DNA kits in Tibet, as lawmakers mull more export controls on China

Thermo Fisher, an American biotech company, has halted sales of its DNA testing products in Tibet, amid concerns that its products might have assisted the Chinese government in a surveillance campaign in the ethnic region

The Independent UK

Thermo Fisher Scientific and C-CAMP announce collaborative initiative to establish centre of excellence in Bengaluru

Thermo Fisher Scientific and the Centre for Cellular and Molecular Platforms (C-CAMP) recently announced a collaborative initiative to establish a Centre of Excellence in Bengaluru. This state-of-the-art facility will serve as a hub for fostering innovation, accelerating breakthroughs in the biotechnology sector and enabling researchers to enhance their expertise and…

The Hindu

Read news from The Economist, FT, and more,
with one subscription

Stocks Slump as Technology Stocks Plunge on Alphabet’s Disappointing Earnings

What you need to know… The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed down -1.43%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.32%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -2.47%. Stocks on Wednesday retreated, with the S&P 500...

Barchart

Big Tech Losses Weigh on Overall Market as Alphabet Slumps

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.89%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.32%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.35%. Stocks this morning are moderately lower as some disappointing...

Barchart

Medical exploitation of Black people in America goes far beyond the cells stolen from Henrietta Lacks that produced modern day miracles

In a case that revealed the exploitation of a Black woman beginning in the 1950s and extending for 70 years, Thermo Fisher Scientific Inc. settled a lawsuit that the estate of Henrietta Lacks had filed against the biotech firm for its role in what the lawsuit called “a racially unjust…

The Conversation

First Thing: Donald Trump faces four charges over efforts to overturn 2020 election

Latest criminal case before ex-president has come weeks after he was charged with retaining national defense information. Plus, experts warn of record US deaths from extreme heat

The Guardian - UK

Henrietta Lacks’ family settles lawsuit with a biotech company that used her cells without consent

Family of Henrietta Lacks settles lawsuit with biotechnology company over her cells, which were taken without her knowledge and used to develop medical innovations. After 70 years, Lacks' descendants reach settlement with Thermo Fisher Scientific Inc. over unjust enrichment from her cells.

The Hindu

Immortal cells: Henrietta Lacks’ family settle lawsuit over HeLa tissue harvested in 1950s

Cells taken without consent from cancer victim can reproduce indefinitely and were sold for unjust profit by Thermo Fisher Scientific, relatives argued

The Guardian - AU

Family of Henrietta Lacks settles lawsuit against biotech firm Thermo Fisher Scientific

The federal lawsuit in Baltimore claimed Thermo Fisher Scientific has made billions from tissue taken without Henrietta Lacks’s consent from her cervical cancer tumor.

Chicago Sun-Times

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Thermo Fisher Scientific settles with family of Henrietta Lacks, whose HeLa cells uphold medicine

The family of Henrietta Lacks is settling a lawsuit against a biotechnology company it accuses of improperly profiting from her cells

The Guardian - US

Test approved to detect preeclampsia, leading cause of US maternal deaths

FDA approves new test, which has been widely celebrated as a small victory in the fight to make childbirth safer in the US

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Thermo Fisher Scientific

Automatic Data Processing

33 stories

CCAMP

12 stories

Thermo Fisher Scientific Inc

12 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.